MedPath

Measurement of Tricuspid Regurgitation Volume for Assessment of Tricuspid Regurgitation Using 3D Transesophageal Echocardiography

Withdrawn
Conditions
Tricuspid Regurgitation
Registration Number
NCT05130775
Lead Sponsor
Tufts Medical Center
Brief Summary

This study is a prospective observational chart review. The aim of the study is to evaluate tricuspid regurgitation volume using 3D volumetric assessment as an accurate method for tricuspid regurgitation severity in comparison to VCA.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

-All degrees of tricuspid regurgitation minimal, mild, moderate and severe will be included

Exclusion Criteria
  • Exclusion criteria will be non-sinus rhythm, more than mild pulmonary regurgitation, more than trace aortic regurgitation.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tricuspid regurgitation volume12 months

We will evaluate patients with different grades TR by both 3DVCA and the 3D volumetric approach

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Tufts Medical Center

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath